| Bioactivity | Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) is the legumain substrate. Overexpressed legumain in 293 HEK-Leg cells potently cleaved CBZ-Ala-Ala-Asn-AMC[1]. | ||||||
| Invitro | The first legumain fluorogenic substrate Cbz-Ala-Ala-Asn-AMC based on the P3-P2-P1 sequence Ala-Ala-Asn. The synthetic substrate Cbz-Ala-Ala-Asn-AMC is effectively cleaved by S. mansoni legumain and human legumain with Kms of 90 and 80 uM respectively[2][3]. | ||||||
| Name | Z-Ala-Ala-Asn-AMC | ||||||
| CAS | 149697-16-5 | ||||||
| Formula | C28H31N5O8 | ||||||
| Molar Mass | 565.57 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Z-Ala-Ala-Asn-AMC
CAS: 149697-16-5 F: C28H31N5O8 W: 565.57
Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) is the legumain substrate. Overexpressed legumain in 293 HEK-Leg cells potently
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.